PET scan for high-risk prostate cancer before surgery
Treatments studied
Part of Cancer, Kidney & urinary clinical trials.
This trial uses a special PET scan to find prostate cancer cells before surgery. It may help doctors see where the cancer is located and if it has spread.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old.
- You have prostate cancer that has not been treated yet, confirmed by a biopsy.
- Your cancer is high-risk or higher (for example, it has spread outside the prostate, has a high Gleason score, or your PSA is over 20).
- You plan to have surgery (radical prostatectomy) and have your lymph nodes removed.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a special PET scan using PSMA-1007 can find prostate cancer spread in men who have just been diagnosed with high-risk prostate cancer and plan to have surgery. The scan may help doctors better understand the cancer before removing the prostate and lymph nodes.
This trial is testing whether a special scan (PSMA PET/CT) before surgery can help doctors decide if you need to remove lymph nodes. It is for men with high-risk prostate cancer who are already planning to have robot-assisted prostate removal.
This trial tests whether a special PET/MRI scan can better see the extent of prostate cancer before surgery. It aims to help doctors plan more precise treatment.
This trial tests a new type of PET scan that looks for a protein called uPAR on prostate cancer cells. It might help doctors see your cancer more clearly without needing surgery or treatment first.
This trial tests a high-precision scan that uses a prostate cancer marker to show where cancer may be. The goal is to use the scan results to better plan treatment, especially around surgery and lymph nodes, in certain patients with prostate cancer.
This trial uses a special PET/MR scan to help doctors aim stereotactic radiation more precisely for certain higher-risk or unfavorable intermediate prostate cancers. It studies whether this targeted approach can safely treat the prostate (and specific areas needing extra treatment) without spreading to the body.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.